Global and China Conjugate Vaccine Industry Market Research Report (2017-2028)

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Conjugate Vaccine industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Bavarian Nordi

    • Daiichi Sankyo Company

    • Johnson & Johnson

    • Medimmune

    • Fablife

    • Pfizer

    • Merck

    • Serum Institute of India

    • Mitsubishi Tanabe Pharma

    • Emergent BioSolutions

    • CSL

    • GlaxoSmithKline

    • Sanofi Pasteur

    • Sinovac Biotech

    • Astellas Pharma

    • SutroVax

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Monovalent

    • Multivalent

    Application:

    • Hospitals

    • Clinics

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Conjugate Vaccine Industry Overview

      • 1.1.1 Conjugate Vaccine Market Scope and Market Segments

      • 1.1.2 Conjugate Vaccine Industry Characteristics

      • 1.1.3 Global and China Conjugate Vaccine Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Conjugate Vaccine Production Value and Growth Rate (2017-2028)

    • 1.2 Global Conjugate Vaccine Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Monovalent

      • 1.2.2 Multivalent

    • 1.3 Global Conjugate Vaccine Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospitals

      • 1.3.2 Clinics

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Conjugate Vaccine Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Conjugate Vaccine Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Conjugate Vaccine Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Conjugate Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Conjugate Vaccine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Conjugate Vaccine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Conjugate Vaccine Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Conjugate Vaccine Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Conjugate Vaccine Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Conjugate Vaccine Industry Porter's Five Forces Model Analysis

      • 2.2.3 Conjugate Vaccine Industry PEST Analysis

    • 2.3 Conjugate Vaccine Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Conjugate Vaccine Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Conjugate Vaccine Industry

    Chapter 3 Global and China Conjugate Vaccine Market, by Manufacturer

    • 3.1 Global and China Conjugate Vaccine Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Conjugate Vaccine Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Conjugate Vaccine Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Conjugate Vaccine Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Conjugate Vaccine Market Top 3 Players

    Chapter 4 Global and China Conjugate Vaccine Market, by Type (2017-2028)

    • 4.1 Conjugate Vaccine Market Trend, by Type

    • 4.2 Global Conjugate Vaccine Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Conjugate Vaccine Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Conjugate Vaccine Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Conjugate Vaccine Price Trend, by Type (2017-2028)

    • 4.3 China Conjugate Vaccine Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Conjugate Vaccine Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Conjugate Vaccine Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Conjugate Vaccine Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Conjugate Vaccine Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Conjugate Vaccine Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Conjugate Vaccine Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Conjugate Vaccine Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Conjugate Vaccine Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Conjugate Vaccine Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Conjugate Vaccine Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Conjugate Vaccine Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Conjugate Vaccine Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Conjugate Vaccine Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Conjugate Vaccine Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Conjugate Vaccine Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Conjugate Vaccine Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Conjugate Vaccine Market Analysis

    • 7.1 North America Conjugate Vaccine Market, by Type

    • 7.2 North America Conjugate Vaccine Market, by Application

    • 7.3 North America Conjugate Vaccine Market Analysis and Forecast, by Country

      • 7.3.1 United States Conjugate Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Conjugate Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Conjugate Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Conjugate Vaccine Market Analysis

    • 8.1 Europe Conjugate Vaccine Market, by Type

    • 8.2 Europe Conjugate Vaccine Market, by Application

    • 8.3 Europe Conjugate Vaccine Market Analysis and Forecast, by Country

      • 8.3.1 Germany Conjugate Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Conjugate Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Conjugate Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Conjugate Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Conjugate Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Conjugate Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Conjugate Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Conjugate Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Conjugate Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Conjugate Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Conjugate Vaccine Market Analysis

    • 9.1 APAC Conjugate Vaccine Market, by Type

    • 9.2 APAC Conjugate Vaccine Market, by Application

    • 9.3 APAC Conjugate Vaccine Market Analysis and Forecast, by Country

      • 9.3.1 China Conjugate Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Conjugate Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Conjugate Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Conjugate Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Conjugate Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Conjugate Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Conjugate Vaccine Market Analysis

    • 10.1 Latin America, Middle East and Africa Conjugate Vaccine Market, by Type

    • 10.2 Latin America, Middle East and Africa Conjugate Vaccine Market, by Application

    • 10.3 Latin America, Middle East and Africa Conjugate Vaccine Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Conjugate Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Conjugate Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Conjugate Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Conjugate Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Conjugate Vaccine Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Conjugate Vaccine Company Profiles

      • 11.1 Bavarian Nordi

        • 11.1.1 Bavarian Nordi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Bavarian Nordi Conjugate Vaccine Product Profiles, Application and Specification

        • 11.1.3 Bavarian Nordi Conjugate Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Daiichi Sankyo Company

        • 11.2.1 Daiichi Sankyo Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Daiichi Sankyo Company Conjugate Vaccine Product Profiles, Application and Specification

        • 11.2.3 Daiichi Sankyo Company Conjugate Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Johnson & Johnson

        • 11.3.1 Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Johnson & Johnson Conjugate Vaccine Product Profiles, Application and Specification

        • 11.3.3 Johnson & Johnson Conjugate Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Medimmune

        • 11.4.1 Medimmune Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Medimmune Conjugate Vaccine Product Profiles, Application and Specification

        • 11.4.3 Medimmune Conjugate Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Fablife

        • 11.5.1 Fablife Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Fablife Conjugate Vaccine Product Profiles, Application and Specification

        • 11.5.3 Fablife Conjugate Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Pfizer

        • 11.6.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Pfizer Conjugate Vaccine Product Profiles, Application and Specification

        • 11.6.3 Pfizer Conjugate Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Merck

        • 11.7.1 Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Merck Conjugate Vaccine Product Profiles, Application and Specification

        • 11.7.3 Merck Conjugate Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Serum Institute of India

        • 11.8.1 Serum Institute of India Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Serum Institute of India Conjugate Vaccine Product Profiles, Application and Specification

        • 11.8.3 Serum Institute of India Conjugate Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Mitsubishi Tanabe Pharma

        • 11.9.1 Mitsubishi Tanabe Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Mitsubishi Tanabe Pharma Conjugate Vaccine Product Profiles, Application and Specification

        • 11.9.3 Mitsubishi Tanabe Pharma Conjugate Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Emergent BioSolutions

        • 11.10.1 Emergent BioSolutions Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Emergent BioSolutions Conjugate Vaccine Product Profiles, Application and Specification

        • 11.10.3 Emergent BioSolutions Conjugate Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 CSL

        • 11.11.1 CSL Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 CSL Conjugate Vaccine Product Profiles, Application and Specification

        • 11.11.3 CSL Conjugate Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 GlaxoSmithKline

        • 11.12.1 GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 GlaxoSmithKline Conjugate Vaccine Product Profiles, Application and Specification

        • 11.12.3 GlaxoSmithKline Conjugate Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.13 Sanofi Pasteur

        • 11.13.1 Sanofi Pasteur Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.13.2 Sanofi Pasteur Conjugate Vaccine Product Profiles, Application and Specification

        • 11.13.3 Sanofi Pasteur Conjugate Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.14 Sinovac Biotech

        • 11.14.1 Sinovac Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.14.2 Sinovac Biotech Conjugate Vaccine Product Profiles, Application and Specification

        • 11.14.3 Sinovac Biotech Conjugate Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.15 Astellas Pharma

        • 11.15.1 Astellas Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.15.2 Astellas Pharma Conjugate Vaccine Product Profiles, Application and Specification

        • 11.15.3 Astellas Pharma Conjugate Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.16 SutroVax

        • 11.16.1 SutroVax Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.16.2 SutroVax Conjugate Vaccine Product Profiles, Application and Specification

        • 11.16.3 SutroVax Conjugate Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Conjugate Vaccine Industry Investment Prospect and Risk Assessment

    • 12.1 Conjugate Vaccine Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Conjugate Vaccine Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Conjugate Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure China Conjugate Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Global Conjugate Vaccine Production Value and Growth Rate (2017-2028)

    • Figure China Conjugate Vaccine Production Value and Growth Rate (2017-2028)

    • Figure Global Conjugate Vaccine Market Size and Growth Rate of Monovalent (2017-2028)

    • Figure Global Conjugate Vaccine Market Size and Growth Rate of Multivalent (2017-2028)

    • Figure Global Conjugate Vaccine Market Size and Growth Rate of Hospitals (2017-2028)

    • Figure Global Conjugate Vaccine Market Size and Growth Rate of Clinics (2017-2028)

    • Figure North America Conjugate Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Conjugate Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Conjugate Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Conjugate Vaccine Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Conjugate Vaccine Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Conjugate Vaccine Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Conjugate Vaccine Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Conjugate Vaccine Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Conjugate Vaccine Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Conjugate Vaccine Market Share, by Manufacturer in 2021

    • Figure Global and China Conjugate Vaccine Market Share, by Manufacturer in 2022

    • Table Global Conjugate Vaccine Sales Volume, by Type (2017-2028)

    • Table Global Conjugate Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure Global Conjugate Vaccine Sales Volume Share, by Type (2017-2028)

    • Table Global Conjugate Vaccine Sales Value, by Type (2017-2028)

    • Table Global Conjugate Vaccine Sales Value Share, by Type (2017-2028)

    • Figure Global Conjugate Vaccine Price Trend, by Type (2017-2028)

    • Table China Conjugate Vaccine Sales Volume, by Type (2017-2028)

    • Table China Conjugate Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure China Conjugate Vaccine Sales Volume Share, by Type (2017-2028)

    • Table China Conjugate Vaccine Sales Value, by Type (2017-2028)

    • Table China Conjugate Vaccine Sales Value Share, by Type (2017-2028)

    • Figure China Conjugate Vaccine Price Trend, by Type (2017-2028)

    • Table Global Conjugate Vaccine Sales Volume, by Application (2017-2028)

    • Table Global Conjugate Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure Global Conjugate Vaccine Sales Volume Share, by Application (2017-2028)

    • Table Global Conjugate Vaccine Sales Value, by Application (2017-2028)

    • Table Global Conjugate Vaccine Sales Value Share, by Application (2017-2028)

    • Figure Global Conjugate Vaccine Sales Value Share, by Application (2017-2028)

    • Table China Conjugate Vaccine Sales Volume, by Application (2017-2028)

    • Table China Conjugate Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure China Conjugate Vaccine Sales Volume Share, by Application (2017-2028)

    • Table China Conjugate Vaccine Sales Value, by Application (2017-2028)

    • Table China Conjugate Vaccine Sales Value Share, by Application (2017-2028)

    • Figure China Conjugate Vaccine Sales Value Share, by Application (2017-2028)

    • Figure China Conjugate Vaccine Production, Import, Consumption and Export (2017-2022)

    • Figure North America Conjugate Vaccine Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Conjugate Vaccine Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Conjugate Vaccine Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Conjugate Vaccine Production, Import, Consumption and Export (2017-2022)

    • Table North America Conjugate Vaccine Sales Volume, by Type (2017-2028)

    • Table North America Conjugate Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure North America Conjugate Vaccine Sales Volume Share, by Type (2017-2028)

    • Table North America Conjugate Vaccine Sales Volume, by Application (2017-2028)

    • Table North America Conjugate Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure North America Conjugate Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure United States Conjugate Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure United States Conjugate Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Canada Conjugate Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Conjugate Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Conjugate Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Conjugate Vaccine Sales Value and Growth Rate (2017-2028)

    • Table Europe Conjugate Vaccine Sales Volume, by Type (2017-2028)

    • Table Europe Conjugate Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure Europe Conjugate Vaccine Sales Volume Share, by Type (2017-2028)

    • Table Europe Conjugate Vaccine Sales Volume, by Application (2017-2028)

    • Table Europe Conjugate Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure Europe Conjugate Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure Germany Conjugate Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Conjugate Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure UK Conjugate Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure UK Conjugate Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure France Conjugate Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure France Conjugate Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Italy Conjugate Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Conjugate Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Conjugate Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Conjugate Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Spain Conjugate Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Conjugate Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Conjugate Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Conjugate Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Poland Conjugate Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Conjugate Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Russia Conjugate Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Conjugate Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Conjugate Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Conjugate Vaccine Sales Value and Growth Rate (2017-2028)

    • Table APAC Conjugate Vaccine Sales Volume, by Type (2017-2028)

    • Table APAC Conjugate Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure APAC Conjugate Vaccine Sales Volume Share, by Type (2017-2028)

    • Table APAC Conjugate Vaccine Sales Volume, by Application (2017-2028)

    • Table APAC Conjugate Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure APAC Conjugate Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure China Conjugate Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure China Conjugate Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Japan Conjugate Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Conjugate Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Conjugate Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Conjugate Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure India Conjugate Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure India Conjugate Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Conjugate Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Conjugate Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Conjugate Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Conjugate Vaccine Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Conjugate Vaccine Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Conjugate Vaccine Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Conjugate Vaccine Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Conjugate Vaccine Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Conjugate Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Conjugate Vaccine Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Conjugate Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Conjugate Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Conjugate Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Conjugate Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Conjugate Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Conjugate Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Conjugate Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Conjugate Vaccine Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Conjugate Vaccine Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Conjugate Vaccine Sales Value and Growth Rate (2017-2028)

    • Table Bavarian Nordi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bavarian Nordi Product Profiles, Application and Specification

    • Table Bavarian Nordi Conjugate Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Daiichi Sankyo Company Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Daiichi Sankyo Company Product Profiles, Application and Specification

    • Table Daiichi Sankyo Company Conjugate Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Johnson & Johnson Product Profiles, Application and Specification

    • Table Johnson & Johnson Conjugate Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Medimmune Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Medimmune Product Profiles, Application and Specification

    • Table Medimmune Conjugate Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Fablife Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Fablife Product Profiles, Application and Specification

    • Table Fablife Conjugate Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Product Profiles, Application and Specification

    • Table Pfizer Conjugate Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Merck Product Profiles, Application and Specification

    • Table Merck Conjugate Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Serum Institute of India Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Serum Institute of India Product Profiles, Application and Specification

    • Table Serum Institute of India Conjugate Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Mitsubishi Tanabe Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Mitsubishi Tanabe Pharma Product Profiles, Application and Specification

    • Table Mitsubishi Tanabe Pharma Conjugate Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Emergent BioSolutions Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Emergent BioSolutions Product Profiles, Application and Specification

    • Table Emergent BioSolutions Conjugate Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table CSL Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table CSL Product Profiles, Application and Specification

    • Table CSL Conjugate Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GlaxoSmithKline Product Profiles, Application and Specification

    • Table GlaxoSmithKline Conjugate Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sanofi Pasteur Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sanofi Pasteur Product Profiles, Application and Specification

    • Table Sanofi Pasteur Conjugate Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sinovac Biotech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sinovac Biotech Product Profiles, Application and Specification

    • Table Sinovac Biotech Conjugate Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Astellas Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Astellas Pharma Product Profiles, Application and Specification

    • Table Astellas Pharma Conjugate Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table SutroVax Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table SutroVax Product Profiles, Application and Specification

    • Table SutroVax Conjugate Vaccine Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.